Libtayo (cemiplimab)

pCPA File Number: 21794
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of patients with locally advanced or metastatic basal cell carcinoma (BCC) previously treated with a hedgehog pathway inhibitor.
Sponsor/Manufacturer:
Sanofi Genzyme
CADTH Project Number:
PC0260
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable